All Substitutes
Loading...
Disclaimer
Did you find this information helpful?
Fosaport 150mg Injection
Prescription Required
Salt Composition : Fosaprepitant Dimeglumine
Manufacturer : BIOCON LTD
Origin of Medicine : India
1 Vial(s)
Introduction to Fosaport 150mg Injection
Fosaport 150mg Injection is an antiemetic medication containing the active constituent Fosaprepitant dimeglumine. It is used to prevent nausea and vomiting caused by chemotherapy (cancer treatment). It is not recommended for children under six months of age or who weigh less than 6kg.
It is important to inform your physician about all the medications you are taking recently, including supplements and herbal medicines, before taking Fosaport 150mg Injection Injection. This medication may reduce the efficacy of hormonal contraceptives. Talk with your doctor about alternative birth control options.
Before taking this medication, you need to inform your doctor if you have liver disorders, allergic conditions, or other diseases. Indigestion, tiredness, headache, and loss of appetite are the common side effects of Fosaport 150mg Injection Injection.
Uses of Fosaport 150mg Injection
Fosaport 150mg Injection is used in the treatment of the following:
- Acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC), including high-dose cisplatin.
- Delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC).
Therapeutic Effects of Fosaport 150mg Injection
Fosaport 150mg Injection works by being converted into aprepitant, a selective antagonist of neurokinin 1 (NK1) receptors in the brain. It blocks substance P from binding to these receptors, preventing chemotherapy-induced nausea and vomiting (CINV). Aprepitant also enhances the effectiveness of other antiemetic drugs, such as ondansetron and dexamethasone, inhibiting both the acute and delayed phases of emesis caused by chemotherapy agents like cisplatin.
Interaction of Fosaport 150mg Injection with other drugs
Inform your doctor about any prescribed medications, over-the-counter medicines, vitamin or nutritional supplements, and herbal products that you are taking or have taken before the Fosaport 150mg Injection.
More Information about Fosaport 150mg Injection
- Keep out of reach of children and pets.
- Store the Fosaport injection in the original packaging to protect from moisture.
- Avoid direct sunlight
- Store Fosaport 150mg Injection at a temperature between 2°C to 8°C.
How to consume Fosaport 150mg Injection
Fosaport 150mg Injection will be administered to you intravenously by a healthcare professional or nurse in a healthcare setting. Do not self-administer this medication. For dosage adjustments or any concerns, please consult your healthcare provider.
Safety Advices for Fosaport 150mg Injection
Pregnancy
There are no established adverse effects of the Fosaport 150mg Injection during the administration of pregnancy. Inform your physician if you are pregnant or planning to get pregnant before taking this medication. It will be given to you by your healthcare professional.
Breast Feeding
It is unknown if it is safe to take Fosaport 150 mg Injection while breastfeeding. Consult your healthcare provider before starting treatment if you are breastfeeding.
Lungs
If you have any pre-existing lung conditions, discuss them with your doctor before starting treatment with Fosaport 150mg Injection.
Liver
If you have any pre-existing lung conditions, discuss them with your doctor before starting treatment with Fosaport 150mg Injection.
Alcohol
It is unknown whether alcohol consumption is safe while you are undergoing a Fosaport 150mg Injection course. It is recommended to consult your doctor for better guidance.
Driving
Fosaport 150mg Injection does not typically cause drowsiness or impair your ability to drive. However, if you experience any dizziness or unusual symptoms, consult your healthcare provider.
Side Effects of Fosaport 150mg Injection
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Serious side effects of Fosaport 150mg Injection are:
- Skin blistering, peeling
- Rash, itching, difficulty breathing, or swallowing
Common side effects of Fosaport 150mg Injection are:
- Fatigue
- Indigestion, constipation
- Loss of appetite
- Hiccups
Word of Advice
The Fosaport 150mg Injection should be administered only by the doctor or nurse, and do not self-administer this injection. Inform the doctor if the patient has any history of allergic reactions, liver or kidney problems, and other medication taken for different medical conditions. Consult the doctor if the patient is planning for pregnancy or breastfeeding mother before taking this medication. Avoid driving and handling heavy machinery as it causes dizziness. Patients may feel a lack of concentration and alertness.
FAQs
Q 1. Is Fosaport 150mg Injection a chemotherapy medication?
It is an antiemetic medication that prevents nausea and vomiting caused by chemotherapy (cancer treatment)
Q 2. Can I drive after using Fosaport 150mg Injection?
No, avoid driving, as this medication can cause dizziness. Patients may lack concentration and alertness.
Q 3. Can I drink while using Fosaport 150mg Injection?
It is unsafe to use this medication while consuming alcohol because it reduces the effectiveness of the medicine.
Q 4. Can Fosaport 150mg Injection be used in pregnancy?
No, it is not recommended in patients during pregnancy or who are planning for pregnancy as it causes harmful effects on the developing baby.
Q 5. Can Fosaport 150mg Injection be given for liver disorders?
This injection is used with caution in severe liver disorders, and dosage adjustment is required. Consult the doctor before taking this medication.
Q 6. Can Fosaport 150mg Injection be given in children?
No, this injection is not recommended for children under six months of age or who weigh less than 6kg. Consult the doctor before taking this injection.
Fact Box of Fosaport 150mg Injection
Molecule name: Fosaprepitant | Therapeutic class: NK 1 Receptor antagonist |
Pharmacological class: Antiemetic agents | Indications: To prevent nausea and vomiting due to chemotherapy. |
References
1. KD Tripathi, Essentials of Medical Pharmacology, Antiemetic, Prokinetic and Digestant Drugs, 7th edition, 2013, 669-670.
2. Merck Sharp & Dohme Corp, US Food and Drug Administration, [Revised date Feb 2016], [Accessed date 2nd April 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022023s014lbl.pdf
3. National Cancer Institute, [Accessed date 2nd April 2021] +https://www.cancer.gov/publications/dictionaries/cancer-terms/def/fosaprepitant-dimeglumine
Disclaimer
MrMed’s primary intention is to ensure that its consumers get accurate and trustworthy information that is reviewed by experts. The contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
